Display Settings:

Items per page
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 6

1.
Figure  6

Figure 6. From: BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer.

Pedigree of the family carrying the 6696delTC mutation. Circles denote women; squares denote men. Individuals affected with cancer (blackened symbols) and unaffected individuals (unblackened symbols) are both indicated. A diagonal line through a symbol indicates that the individual denoted is dead.

Roxana Moslehi, et al. Am J Hum Genet. 2000 April;66(4):1259-1272.
2.
Figure  1

Figure 1. From: BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer.

Cumulative incidence of ovarian cancer to age 75 years in female first-degree relatives of women with cancer and control women. We observed 20 ovarian cancers among the 638 female relatives of women with ovarian cancer and 10 ovarian cancers among the 1,130 female relatives of control women (P=.0015).

Roxana Moslehi, et al. Am J Hum Genet. 2000 April;66(4):1259-1272.
3.
Figure  2

Figure 2. From: BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer.

Cumulative incidence of breast cancer to age 75 years in female first-degree relatives of women with cancer and control women. We observed 63 breast cancers among the 638 female relatives of cases with ovarian cancer and 50 breast cancers among the 1,130 female relatives of control women (P<.0001).

Roxana Moslehi, et al. Am J Hum Genet. 2000 April;66(4):1259-1272.
4.
Figure  5

Figure 5. From: BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer.

Cumulative incidence of breast cancer to age 75 years in female first-degree relatives of women with serous and nonserous ovarian cancer and control women. We observed 37 breast cancers among the 305 female relatives of women with serous ovarian cancer, 9 breast cancers among the 141 female relatives of women with nonserous ovarian cancer, and 50 ovarian cancers among the 1,130 female relatives of control women (P<.0001).

Roxana Moslehi, et al. Am J Hum Genet. 2000 April;66(4):1259-1272.
5.
Figure  3

Figure 3. From: BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer.

Cumulative incidence of ovarian cancer to age 75 years in female first-degree relatives of carriers, noncarriers, and controls. We observed 13 ovarian cancers among the 253 female relatives of carrier women with ovarian cancer, 7 ovarian cancers among the 368 female relatives of noncarrier cases, and 10 ovarian cancers among the 1,130 female relatives of control women (P<.0001).

Roxana Moslehi, et al. Am J Hum Genet. 2000 April;66(4):1259-1272.
6.
Figure  4

Figure 4. From: BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer.

Cumulative incidence of breast cancer to age 75 years in female first-degree relatives of carriers, noncarriers, and controls. We observed 36 breast cancers among the 253 female relatives of carrier women with ovarian cancer, 27 breast cancers among the 368 female relatives of noncarrier women, and 50 ovarian cancers among the 1,130 female relatives of control women (P<.0001).

Roxana Moslehi, et al. Am J Hum Genet. 2000 April;66(4):1259-1272.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk